AP-1, an intracellular transcription activator, binds to the promoter region of the VEGF gene [15] and upregulates VEGF expression in many cancers, including head and neck cancer [16], breast cancer [17], colon carcinoma [18], and ovarian carcinoma [19]. Here, VEGFA is linked to breast cancer.